BDX
Price
$176.81
Change
-$1.26 (-0.71%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
50.07B
34 days until earnings call
Intraday BUY SELL Signals
RMD
Price
$218.84
Change
-$2.31 (-1.04%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
32.04B
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDX vs RMD

BDX vs RMD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDX vs. RMD commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and RMD is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BDX vs RMD: Fundamental Ratings
BDX
RMD
OUTLOOK RATING
1..100
666
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
14
Undervalued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
8540
PRICE GROWTH RATING
1..100
4357
P/E GROWTH RATING
1..100
4470
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDX's Valuation (5) in the Medical Specialties industry is in the same range as RMD (14). This means that BDX’s stock grew similarly to RMD’s over the last 12 months.

BDX's Profit vs Risk Rating (96) in the Medical Specialties industry is in the same range as RMD (100). This means that BDX’s stock grew similarly to RMD’s over the last 12 months.

RMD's SMR Rating (40) in the Medical Specialties industry is somewhat better than the same rating for BDX (85). This means that RMD’s stock grew somewhat faster than BDX’s over the last 12 months.

BDX's Price Growth Rating (43) in the Medical Specialties industry is in the same range as RMD (57). This means that BDX’s stock grew similarly to RMD’s over the last 12 months.

BDX's P/E Growth Rating (44) in the Medical Specialties industry is in the same range as RMD (70). This means that BDX’s stock grew similarly to RMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDXRMD
RSI
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 2 days ago
55%
MACD
ODDS (%)
Bearish Trend 4 days ago
44%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 5 days ago
45%
Bullish Trend 4 days ago
58%
Declines
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 11 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
56%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (BDX: $178.07 vs. RMD: $221.15)
Brand notoriety: BDX and RMD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BDX: 70% vs. RMD: 65%
Market capitalization -- BDX: $50.07B vs. RMD: $32.04B
BDX [@Pharmaceuticals: Other] is valued at $50.07B. RMD’s [@Pharmaceuticals: Other] market capitalization is $32.04B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $146.54B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 1 FA rating(s) are green while RMD’s FA Score has 1 green FA rating(s).

  • BDX’s FA Score: 1 green, 4 red.
  • RMD’s FA Score: 1 green, 4 red.
According to our system of comparison, BDX is a better buy in the long-term than RMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 3 TA indicator(s) are bullish while RMD’s TA Score has 4 bullish TA indicator(s).

  • BDX’s TA Score: 3 bullish, 6 bearish.
  • RMD’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both BDX and RMD are a bad buy in the short-term.

Price Growth

BDX (@Pharmaceuticals: Other) experienced а -0.65% price change this week, while RMD (@Pharmaceuticals: Other) price change was -0.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.16%. For the same industry, the average monthly price growth was -5.15%, and the average quarterly price growth was +14.09%.

Reported Earning Dates

BDX is expected to report earnings on Nov 05, 2026.

RMD is expected to report earnings on Oct 22, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.16% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
BDX
Daily Signal:
Gain/Loss:
RMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZCMD0.880.01
+1.59%
Zhongchao Inc
SN179.78-0.34
-0.19%
SharkNinja
BLDP2.02-0.02
-0.98%
Ballard Power Systems
MANU20.62-0.33
-1.58%
Manchester United PLC
TNYA0.57-0.04
-6.28%
Tenaya Therapeutics

BDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
-0.52%
COO - BDX
55%
Loosely correlated
+1.56%
TMO - BDX
50%
Loosely correlated
-3.34%
BAX - BDX
49%
Loosely correlated
-1.50%
CNMD - BDX
48%
Loosely correlated
-0.65%
MMSI - BDX
48%
Loosely correlated
-0.09%
More

RMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMD has been loosely correlated with BAX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then BAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMD
1D Price
Change %
RMD100%
+0.02%
BAX - RMD
46%
Loosely correlated
-1.50%
BDX - RMD
46%
Loosely correlated
-0.52%
SOLV - RMD
43%
Loosely correlated
-0.43%
ISRG - RMD
41%
Loosely correlated
-1.33%
COO - RMD
40%
Loosely correlated
+1.56%
More